Genetic signature to provide robust risk assessment of psoriatic arthritis development in psoriasis patients

[1]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[2]  Abhijit Ghatak,et al.  Machine Learning with R , 2017, Springer Singapore.

[3]  A. Ogdie The preclinical phase of PsA: a challenge for the epidemiologist , 2017, Annals of the rheumatic diseases.

[4]  Jingbo Shang,et al.  Stepwise Distributed Open Innovation Contests for Software Development: Acceleration of Genome-Wide Association Analysis , 2017, GigaScience.

[5]  Lauren Harrison,et al.  The effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BL , 2017, Oncotarget.

[6]  James T. Elder,et al.  Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants , 2016, Nature Communications.

[7]  D. Gladman,et al.  Psoriatic Arthritis. , 2017, The New England journal of medicine.

[8]  L. Coates,et al.  Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same? , 2016, Seminars in arthritis and rheumatism.

[9]  Alan M. Kwong,et al.  Next-generation genotype imputation service and methods , 2016, Nature Genetics.

[10]  Matti Pirinen,et al.  Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis , 2016, Nature Communications.

[11]  Christian Gieger,et al.  Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation , 2016, Science Advances.

[12]  Brian L Browning,et al.  Genotype Imputation with Millions of Reference Samples. , 2016, American journal of human genetics.

[13]  Bernd Bischl,et al.  mlr: Machine Learning in R , 2016, J. Mach. Learn. Res..

[14]  James T. Elder,et al.  Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. , 2015, American journal of human genetics.

[15]  P. Helliwell,et al.  Natural History, Prognosis, and Socioeconomic Aspects of Psoriatic Arthritis. , 2015, Rheumatic diseases clinics of North America.

[16]  M. Husni,et al.  Comorbidities in Psoriatic Arthritis. , 2015, Rheumatic diseases clinics of North America.

[17]  A. Alcina,et al.  Genome-wide significant association with seven novel multiple sclerosis risk loci , 2015, Journal of Medical Genetics.

[18]  Heidi L. Rehm,et al.  Building the foundation for genomics in precision medicine , 2015, Nature.

[19]  Gabor T. Marth,et al.  A global reference for human genetic variation , 2015, Nature.

[20]  Casey S. Greene,et al.  International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways , 2015, Nature Communications.

[21]  Jasjit S. Suri,et al.  Reliable and accurate psoriasis disease classification in dermatology images using comprehensive feature space in machine learning paradigm , 2015, Expert Syst. Appl..

[22]  J. Ortonne,et al.  Prevalence of undiagnosed psoriatic arthritis among psoriasis patients: Systematic review and meta-analysis. , 2015, Journal of the American Academy of Dermatology.

[23]  O. FitzGerald,et al.  Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis. , 2015, Annals of the rheumatic diseases.

[24]  Vinod Chandran,et al.  Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci , 2015, Nature Communications.

[25]  Carson C Chow,et al.  Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.

[26]  M. Daly,et al.  Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants , 2014, Nature.

[27]  C. Griffiths,et al.  Psoriasis: the future. , 2015, Dermatologic clinics.

[28]  R. Mössner,et al.  Complex role of TNF variants in psoriatic arthritis and treatment response to anti-TNF therapy: evidence and concepts. , 2014, The Journal of investigative dermatology.

[29]  Vinod Chandran,et al.  Fine Mapping Major Histocompatibility Complex Associations in Psoriasis and Its Clinical Subtypes , 2014, American journal of human genetics.

[30]  D. Gladman,et al.  Is the Madrid Sonographic Enthesitis Index Useful for Differentiating Psoriatic Arthritis from Psoriasis Alone and Healthy Controls? , 2014, The Journal of Rheumatology.

[31]  D. Gladman,et al.  Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. , 2013, Journal of the American Academy of Dermatology.

[32]  H. Hakonarson,et al.  Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease. , 2013, American journal of human genetics.

[33]  Buhm Han,et al.  Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.

[34]  Philip G Conaghan,et al.  MRI and ultrasonography for diagnosis and monitoring of psoriatic arthritis. , 2012, Best practice & research. Clinical rheumatology.

[35]  James T. Elder,et al.  Identification of fifteen new psoriasis susceptibility loci highlights the role of innate immunity , 2012, Nature Genetics.

[36]  C. Ouzounis,et al.  Transcriptome classification reveals molecular subtypes in psoriasis , 2012, BMC Genomics.

[37]  Paul Marjoram,et al.  Genotype Imputation for Latinos Using the HapMap and 1000 Genomes Project Reference Panels , 2012, Front. Gene..

[38]  R. Winchester,et al.  HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. , 2012, Arthritis and rheumatism.

[39]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[40]  O. Delaneau,et al.  A linear complexity phasing method for thousands of genomes , 2011, Nature Methods.

[41]  James T. Elder,et al.  Genome-wide meta-analysis of Psoriatic Arthritis Identifies Susceptibility Locus at REL , 2011, The Journal of investigative dermatology.

[42]  D. Gladman,et al.  Do patients with psoriatic arthritis who present early fare better than those presenting later in the disease? , 2011, Annals of the rheumatic diseases.

[43]  Tianxi Cai,et al.  Validation of psoriatic arthritis diagnoses in electronic medical records using natural language processing. , 2011, Seminars in arthritis and rheumatism.

[44]  Christian Gieger,et al.  Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis , 2010, Nature Genetics.

[45]  Christian Gieger,et al.  Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2 , 2010, Nature Genetics.

[46]  Yun Li,et al.  METAL: fast and efficient meta-analysis of genomewide association scans , 2010, Bioinform..

[47]  Pui-Yan Kwok,et al.  Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways , 2008, Nature Genetics.

[48]  P. Voulgari,et al.  Incidence and prevalence of psoriatic arthritis: a systematic review. , 2008, The Journal of rheumatology.

[49]  Scott F. Saccone,et al.  A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease Loci , 2008, PLoS genetics.

[50]  Dafna Gladman,et al.  Classification criteria for psoriatic arthritis: development of new criteria from a large international study. , 2006, Arthritis and rheumatism.

[51]  P. Atasoy,et al.  Examination of Bcl‐2, Bcl‐X and bax protein expression in psoriasis , 2003, International journal of dermatology.

[52]  M. Heenen,et al.  Apoptosis in Established and Healing Psoriasis , 2000, Dermatology.

[53]  W. Eyler,et al.  PSORIATIC ARTHRITIS. , 1965, Henry Ford Hospital medical bulletin.

[54]  Judith Scott Clayton,et al.  The Future , 2001, Nature.